Last update 07 Feb 2026

AVA-NP-695

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AVA-NP-695, AVA-NP695
Target
ENPP1
Action
inhibitors
Mechanism
ENPP1 inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 inhibitors)
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
OsteosarcomaMetastatic osteosarcomaBreast Cancer
Inactive Indication-
Originator Organization
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
Active Organization
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
The University of California, San FranciscoThe University of California, San FranciscoUniversity of CaliforniaUniversity of California
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with AVA-NP-695
Login to view more data
100 Translational Medicine associated with AVA-NP-695
Login to view more data
100 Patents (Medical) associated with AVA-NP-695
Login to view more data
100 Deals associated with AVA-NP-695
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteosarcomaPreclinical
United States
The University of California, San FranciscoThe University of California, San Francisco
27 Apr 2025
Metastatic osteosarcomaPreclinical
United States
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
05 Nov 2024
Metastatic osteosarcomaPreclinical
United States
University of CaliforniaUniversity of California
05 Nov 2024
Breast CancerPreclinical
United States
Avammune Therapeutics, Inc.Avammune Therapeutics, Inc.
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free